Investor Type
LinkedIn View on LinkedIn
Mark Lampert of Build Capital Group and former Daimler executive.
Overview
Partner Investments
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
 Structure Therapeutics |  Biotechnology Value Fund | Series B - Structure Therapeutics | |||
 Nimbus Therapeutics | Biotechnology Value Fund | Venture Round - Nimbus Therapeutics | |||
 Xos Trucks |  BUILD Capital Partners | Series A - Xos Trucks | |||
 Merus | Biotechnology Value Fund | Post-IPO Equity - Merus | |||
 BiolineRx | Biotechnology Value Fund | Post-IPO Equity - BiolineRx |
Board and Advisor Roles
Recent News and Activity
There is no recent news or activity for this profile.
